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Abstract: 
Two new sesquiterpene alkaloids, 1β-hydroxy-2β,5α,11-triacetoxy-7β-nicotinoyl-8β-benzoyl-
dihydroagarofuran (1), and 1β,5α,11-triacetoxy-7β-nicotinoyl-8β-benzoyl-dihydroagarofuran (2) 
were isolated from the xylem of Tripterygium wilfordii, together with six known compounds. 
Their structures were elucidated on the basis of spectroscopic studies. 
 
Article: 
INTRODUCTION 
Plants of the genus Tripterygium (Celastraceae) have been used in traditional Chinese medicine 
for treatment of cancer and as an insecticide for hundreds of years. Over the past several decades, 
the plants of the genus Tripterygium, particularly, their xylem extracts, have widely been used in 
clinical treatment of rheumatoid arthritis, skin disorders, male-fertility control, and other 
inflammatory and autoimmune diseases [1-3]. We have previously reported some anti-HIV 
agents, triptonines A and B, along with several related compounds from Tripterygium wilfordii 
in our studies on the bioactive metabolites of this genus [4-6]. This paper deals with the isolation 
and structure determination of two new sesquiterpene alkaloids named wilforsinines A (1) and B 
(2), as well as six known compounds (3–8) from the xylem of Tripterygium wilfordii. 
Compounds 3–8 were isolated from the xylem of this plant for the first time. 
 
RESULTS AND DISCUSSION 
Wilforsinine A (1) was obtained as maize crystal, having a molecular formula of C34H39O12N 
from HREIMS. There was an ester carbonyl band at 1735 cm–1 in the IR spectrum, and the UV 
spectrum showed the presence of an aromatic moiety (225 and 265 nm). The 1H NMR spectral 
data of 1 revealed the presence of three acetyl methyls (δH 2.12, 2.02, and 1.94), a nicotinoyl 
group [δH 9.25 (1H, d, J = 1.6 Hz), 8.81 (1H, br t, J = 3.3 Hz), 8.40 (1H, br d, J = 8.0 Hz), 7.47 
(1H, m)], a benzoyl group [δH 7.85 (2H, d, J = 7.8 Hz), 7.51 (1H, t, J = 7.4 Hz), 7.34 (2H, dd, 
J = 7.8, 7.4 Hz)], an oxygenated methylene [δH 5.26, 4.94 (each 1H, d, J = 12.4 Hz)], as well as 
five methine protons (δH 6.23, 5.96, 5.86, 5.23 and 4.39). The 13C NMR spectral data of 1 
revealed the presence of six methyls, one oxygenated methylene, and five oxygenated methine 
carbons, in addition to two methines, five ester carbonyl carbons, three quaternary carbons, one 
nicotinoyl group [δC 164.5 (s), 153.6 (d), 151.0 (d), 137.3 (d), 125.9 (s), 123.5 (d)], and one 
benzoyl group [δC 165.2 (s), 133.2 (d), 129.8 (s), 129.5 (d), 128.4 (d)]. From the above 
information, compound 1 should be a sesquiterpene polyol ester having a dihydroagarofuran 
skeleton as found in the genus Tripterygium [7-9]. 
 
The 1H–1H COSY spectrum of 1 revealed two separated spin–spin system (H-1/H-2/H-3/H-4, H-
6/H-7/H-8) in the dihydroagarofuran skeleton. The remaining dihydroagarofuran proton signal at 
δH 6.23 (H-5) was correlated with the carbon signals at δC 53.2 (C-6), 73.7 (C-7), 50.8 (C-9), 
89.8 (C-10) and 81.4 (C-13) in the HMBC spectrum. 
 
From the HMBC spectrum, the proton signal of benzoyl (δH 7.85) and the methine proton signal 
(δH 5.96, H-8) were correlated with the carbonyl carbon signal at δC 165.2, and the proton signal 
at δH 5.86 (H-7) with the resonance at δC 164.5 (nicotinoyl), while the signals at δH 5.23 (H-2), 
6.23 (H-5) and 4.94 (H-11a) were correlated with the acetyl carbonyl carbons at δC 170.6, 169.7, 
and 169.8, respectively. From above observations, the nicotinoyl and benzoyl groups were 
assigned at positions C-7 and C-8, and three acetyl groups were assigned at positions C-2, C-5 
and C-11, respectively. Acetylation of 1 afforded 1a, the proton signal at δH 4.39 (H-1, in 1) 
shifted to the downfield region at δH 5.60 in 1a. Thus, the hydroxyl group was located at position 
C-1. 
 
In the NOESY spectrum of 1, the proton signal at δH 4.39 (H-1) correlated with the signals at δH 
5.96 (H-8) and 5.23 (H-2), the proton signal at δH 5.96 (H-8) with the signal at δH 5.86 (H-7) and 
1.64 (H3-14), and the proton signal at δH 5.26 (H-11b) correlated with the signals at δH 6.23 (H-
5) and 1.23 (H3-12). Thus, the relative stereochemistry of the ester and hydroxyl groups were 
elucidated as having the 1β, 2β, 5α, 7β and 8β configurations. The 1H and 13C NMR assignments 
were obtained by 2D NMR spectra including NOESY. Therefore, the structure of wilforsinine A 
(1) was determined as shown in figure 1. 
 
 
Figure 1: Structures of compounds 1–8. 
Wilforsinine B (2), C34H39O11N, revealed signals for three acetyl groups (δH 2.17, 1.97, and 
1.49), a benzoyl group [δH 7.93 (2H, d, J = 7.1 Hz), 7.58 (1H, t, J = 7.4 Hz), 7.43 (2H, dd, 
J = 7.4, 7.1 Hz)], and a nicotinoyl group [δH 9.14 (1H, br s), 8.75 (1H, m), 8.31 (1H, br d, 
J = 8.0 Hz), 7.55 (1H, m)], as well as four methine protons [δH 6.82, 5.84, 5.81, 5.47] in its 1H 
NMR spectrum. The 13C NMR spectral data were similar to those of 1, except for the C-1, -2 and 
-3 carbon signals (table 1). Compound 2 was also a dihydroagarofuran polyol ester and was 
presumed to be 1-acetyl-2-deacetoxy of 1. In the HMBC spectrum of 2, the proton signals at δH 
8.31 (nicotinoyl) and 5.84 (H-7) correlated with the carbonyl carbon signal at δC 165.9, and the 
signals at δH 7.93 (benzoyl group) and 5.81 (H-8) with the carbon signal at δC 166.4, while the 
signals at δH 5.47 (H-1), 6.82 (H-5) and 4.83 (H-11a) correlated with the acetyl carbon signals at 
δC 171.8, 171.7 and 172.2, respectively. Thus, the nicotinoyl and benzoyl groups were assigned 
at positions C-7 and C-8, and three acetyl groups were located at positions C-1, C-5 and C-11. In 
the NOESY spectrum, the proton signal at δH 4.83 (H-11a) correlated with the proton signals at 
6.82 (H-5) and 1.07 (H3-12), and the proton signal at δH 5.81 (H-8) with the signals at δH 5.47 
(H-1) and 1.63 (H3-14), while the signal at δH 5.84 (H-7) correlated with the signal at δH 1.63 
(H3-14). Therefore, the relative configurations of ester groups of 2 were determined as 1β, 5α, 7β 
and 8β (figure 1). 
 
Table 1: 1H NMR and 13C NMR spectral data of 1 and 2. 
  1 (CDCl3)   2 (CD3OD)  
No.  13C  1H   13C  1H  
 1 76.6 4.39 (m)  80.7 5.47 (m) 
 2 73.6 5.23 (m)  24.3 1.83, 1.68 (m) 
 3 33.2 2.30, 1.90 (m)  27.5 2.24, 1.55 (m) 
 4 31.2 2.33 (m)  34.9 2.32 (m) 
 5 74.7 6.23 (s)  76.1 6.82 (s) 
 6 53.2 2.70 (d, 4.1)  54.6 2.72 (d, 3.8) 
 7 73.7 5.86 (dd, 5.6, 4.1)  73.2 5.84 (dd, 5.9, 3.8) 
 8 72.2 5.96 (d, 5.6)  74.4 5.81 (d, 5.9) 
 9 50.8 –  52.4 – 
10 89.8 –  92.2 – 
11 64.0 5.26, 4.94 (d, 12.4)  62.0 4.83, 4.72 (d, 13.3) 
12 18.1 1.21 (d, 7.7)  15.6 1.07 (d, 7.5) 
13 81.4 –  82.5 – 
14 24.5 1.64 (s)  24.8 1.63 (s) 
15 30.4 1.46 (s)  30.8 1.52 (s) 
 
 
The known compounds were identified by spectral comparison with 8,11,13-abietatriene-3-one 
(3) [10], triptoquinone F (4) [11], hinokione (5) [12], triptoquinone A (6) [11], triptobenzene H 
(7) [13] and triptoquinone B (8) [11], respectively. 
 
EXPERIMENTAL 
General experimental procedures 
NMR experiments were run on a Bruker AVANCE 300 instrument. 1H NMR (300 MHz), 13C 
NMR (75 MHz) both had teramethylsilane as an internal standard. MS data were obtained on a 
JEOL JMS-SX102A instrument. Column chromatography was performed on silica-gel (Qingdao 
Haiyang Chemical Co. Ltd) and Sephadex LH-20 (Amersham Pharmacia Biotech). HPLC was a 
JASCO Gulliver Series with PU-1580 (pump), RI-1530 and UV-1575 (detector). Preparative 
HPLC column was used as follows: ODS (YMC-Pack ODS-A, SH-343-5), GPC (Shodex, 
Asahipak GS-310, 20G, MeOH), Si-HPLC1 (Hibar RT 250-25, Lichrosorb, Si60 7 μm), and Si-
HPLC2 (YMC-pack SIL-06, SH-043-5-06). IR spectra were recorded on a 1710 Infrared Fourier 
Transform spectrometer (Perkin-Elmer). UV spectra were obtained on a UVIKONXS recording 
spectrometer (Bio-Tek). Optical rotation was measured with a MC 241 digital polarimeter 
(Perkin-Elmer). 
 
Plant material 
The xylem rhizomes of Tripterygium wilfordii were purchased from Yueyang, Hunan province, 
and were identified by Professor Wen-Yuan Gao, Department of Pharmacognosy and Natural 
Medicines, Tianjin University. A voucher specimen (D20021018) is deposited at the College of 
Pharmaceuticals and Biotechnology, Tianjin University, China. 
 
Extraction and isolation 
The xylem rhizomes (10 kg) of T. wilfordii were refluxed three times with 95% EtOH (15 l each) 
for 2 h. The extract was concentrated under reduced pressure to give a residue (390 g) which was 
partitioned between chloroform and H2O. The CHCl3 layer was concentrated to a residue of 
112 g. Chromatographic separation was performed with a silica gel column and solvents of 
increasing polarity as mobile phase [petroleum ether/EtOAc (8:1, 5:1, 3:1, 1:1, 1:2, 1:4), EtOAc, 
EtOAc/MeOH (19:1, 9:1, 4:1), MeOH] to give 16 frs. Fraction 10 (2 g) was chromatographed on 
Sephadex LH-20 (MeOH) to give 3 frs. (fr. 10.1–10.3). Fr. 10.1 (840 mg) was separated by 
HPLC (ODS, MeOH/H2O 8:2) to give 12 frs. (fr. 10.1.1.1–10.1.1.12). Fr. 10.1.1.5 (80 mg) and 
Fr. 10.1.1.9 (26 mg) were separated respectively by HPLC (ODS, MeOH/H2O 7:3) to give 1 
(6.5 mg) and 2 (8.5 mg). Fraction 7 (2.4 g) was chromatographed on a silica column 
[CHCl3/MeOH (97:3, 9:1)] to give 10 frs. (fr.7.1–7.10). Fr. 7.7 (85 mg) was separated by HPLC 
(GPC, MeOH) to give 3 (6.5 mg). Fraction 7.3 (210 mg) was separated by Sephadex LH-20 
(MeOH) to give 4 (21 mg). Fraction 6 (2.2 g) was chromatographed on Sephadex LH-20 
(MeOH), then separated by Si-HPLC1 (CHCl3/MeOH 97:3) to give 5 (5.0 mg). Fraction 11 
(8.5 g) was chromatographed on a silica column to give frs. 11.1–11.8. Fraction 11.5 (800 mg) 
was separated by GPC (MeOH), then by Si-HPLC2 (hexane/EtOAc 3:1) to give 6 (8.0 mg) and 7 
(90 mg). Fraction 13 (5.2 g) was chromatographed with middle pressure silica gel column with 
CHCl3/MeOH (98:2, 95:5, 9:1) to give 10 frs. (fr. 13.1–13.10). Fraction 13.6 (245 mg) was 
chromatographed using LH-20 (MeOH), then by Si-HPLC2 (hexane/EtOAc 5:2) to give 8 
(50 mg). 
 
Wilforsinine A (1) was isolated as a maize crystal. − 10.5 (c 0.1, MeOH). UV (MeOH) λmax 
(log ϵ): 225 (4.21), 265 (3.57) nm. IR (KBr) νmax cm–1: 3438, 2920, 2851, 1735, 1593, 1371, 
1292, 1225, 1106, 1042, 743, 713. 1H-NMR (CDCl3), see table 1; δ 2.02 (2-OAc); 2.12 (5-OAc); 
1.94 (11-OAc); 7.85 (2H, d, J = 7.8 Hz), 7.51 (1H, t, J = 7.4 Hz), 7.34 (2H, dd, J = 7.8, 7.4 Hz), 
(8-OBz); 9.25 (1H, d, J = 1.6 Hz), 8.81 (1H, br t, J = 3.3 Hz), 8.40 (1H, br d, J = 8.0 Hz), 7.47 
(1H, m), (7-ONic). 13C-NMR (CDCl3), see table 1; δ 21.3, 170.6 (2-OAc); 21.2, 169.7 (5-OAc); 
21.2, 169.8 (11-OAc); 165.2, 129.5, 128.4, 133.2 (8-OBz); 164.5, 125.9, 137.3, 123.5, 153.6, 
151.0 (7-ONic). EI-MS: m/z 653[M]+(3), 611 (5), 593 (7), 318 (4), 149 (15), 124 (36), 105 (100), 
57 (24). HR-EIMS m/z 653.2457 (calcd for C34H39O12N, 653.2472). 
 
Compound 1 was subjected to acetylation with Ac2O-pyridine for 4 h at room temperature to 
give 1a. 1H-NMR (CDCl3), δ 5.60 (1H, d, J = 3.2 Hz, H-1), 5.41 (1H, m, H-2), 2.50 (m, H-3), 
1.95 (m, H-3), 2.35 (m, H-4), 6.85 (s, H-5), 2.66 (1H, d, J = 3.7 Hz, H-6), 5.79 (1H, m), 5.76 
(1H, m), 5.36 (1H, d, J = 12.5 Hz, H-11), 4.63 (1H, d, J = 13.5 Hz, H-11), 1.16 (1H, d, 
J = 7.7 Hz), 1.53 (3H, s), 1.48 (3H, s), 1.62 (3H, s), 2.08 (3H, s), 2.15 (3H, s), 2.00 (3H, s), 7.90 
(2H, d, J = 7.2 Hz), 7.70 (1H, m), 7.38 (2H, br t, J = 7.2 Hz), (8-OBz); 9.22 (1H, s), 8.78 (1H, br 
t, J = 7.4 Hz), 8.27 (1H, br d, J = 7.4 Hz), 7.53 (1H, m) (7-ONic). 
 
Wilforsinine B (2) was isolated as a colourless crystal. − 34.1 (c 0.1, MeOH). UV (MeOH) 
λmax (log ϵ) δ 225 (4.23), 265 (3.61) nm. IR (KBr) νmax cm− 1: 3448, 2927, 1738, 1592, 1452, 
1371, 1231, 1097, 1025, 743, 713. 1H-NMR (CD3OD), see table 1; δ 1.49 (1-OAc); 2.17 (5-
OAc); 1.97 (11-OAc); 7.93 (2H, d, J = 7.1 Hz), 7.58 (1H, t, J = 7.4 Hz), 7.43 (2H, dd, J = 7.4, 
7.1 Hz), (8-OBz); 9.14 (1H, br s), 8.75 (1H, m), 8.31 (1H, br d, J = 8.0 Hz), 7.55 (1H, m) (7-
ONic). 13C-NMR (CD3OD), see table 1; δ 21.2, 171.7 (1-OAc); 21.6, 172.2 (5-OAc); 21.4, 171.8 
(11-OAc); 166.4, 131.5, 130.8, 129.9, 134.9 (8-OBz); 165.9, 128.0, 139.2, 125.4, 154.5, 151.5 
(7-ONic). EI-MS: m/z 637[M]+(27), 595 (78), 124 (43), 106 (44), 105 (100), 77 (15). HR-EIMS 
m/z 637.2556 (calcd for C34H39O11N, 637.2523). 
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